Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JANUARY 23, 2020

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 68/2013 of the Commission on the catalog. 1306/2013 of the European Parliament and of. Council of 17 December 2013 on financing, management and. 1307/2013 of the European Parliament and of.

Food 45

Food THC Safety Agriculture 45

NORML

FEBRUARY 26, 2019

Like it or not, we’re going to be incurring public safety and public health expenses because it’s legal in Massachusetts… And I think it is time for us to put together our own regulatory and taxing framework,” she said. Rhode Island decriminalized minor marijuana-possession offenses in 2013.

Legalization 150

Legalization Marijuana Vaping Retail 150

The Joint Blog

JUNE 11, 2019

From the 1st of January, 2018, it became legal to buy, carry, use, and grow cannabis sativa without a valid physician’s recommendation. From 1998 to 2013, a total of nineteen more states and the District of Columbia passed similar legislature enabling the use of medical marijuana. Up to six plants were also allowed to growers.

Law 36

Law Marijuana Seed-To-Sale Medicine 36

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. In this position paper, cannabis is an overarching term used to refer to the plant Cannabis sativa. Cannabis sativa with less than 0.3%

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues.

Research and Development 52

Research and Development Medicine Access Media 52